Identification Generic Name (2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide DrugBank Accession Number DB08609 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide (DB08609) ×  Close Weight Average: 430.441  Monoisotopic: 430.117412475  Chemical Formula C 19 H 21 F 3 N 2 O 4 S Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as sulfanilides. These are organic aromatic compounds containing a sulfanilide moiety, with the general structure RS(=O)(=O)NC1=CC=CC=C1. Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Sulfanilides Direct Parent Sulfanilides Alternative Parents Benzenesulfonamides  /  Anilides  /  Benzenesulfonyl compounds  /  N-arylamides  /  Toluenes  /  Organosulfonamides  /  Tertiary alcohols  /  Aminosulfonyl compounds  /  Fluorohydrins  /  Secondary carboxylic acid amides  /  Organopnictogen compounds  /  Organofluorides  /  Organic oxides  /  Alkyl fluorides  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 6 more Substituents Alcohol  /  Alkyl fluoride  /  Alkyl halide  /  Aminosulfonyl compound  /  Anilide  /  Aromatic homomonocyclic compound  /  Benzenesulfonamide  /  Benzenesulfonyl group  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid derivative  /  Fluorohydrin  /  Halohydrin  /  Hydrocarbon derivative  /  N-arylamide  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organic sulfonic acid or derivatives  /  Organofluoride  /  Organohalogen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Organosulfonic acid amide  /  Organosulfonic acid or derivatives  /  Organosulfur compound  /  Secondary carboxylic acid amide  /  Sulfanilide  /  Sulfonyl  /  Tertiary alcohol  /  Toluene 
 
 
  show 22 more Molecular Framework Aromatic homomonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key SHEIQJGQDUYUBE-GOSISDBHSA-N InChI InChI=1S/C19H21F3N2O4S/c1-4-24(14-8-6-5-7-9-14)29(27,28)15-10-11-16(13(2)12-15)23-17(25)18(3,26)19(20,21)22/h5-12,26H,4H2,1-3H3,(H,23,25)/t18-/m1/s1 IUPAC Name N-{4-[ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide SMILES [H]N(C(=O)C(C)(O)C(F)(F)F)C1=C(C)C=C(C=C1)S(=O)(=O)N(CC)C1=CC=CC=C1 References General References Not Available External Links PubChem Compound 6102762 PubChem Substance 99445080 ChemSpider 4810270 ZINC ZINC000001547315 PDBe Ligand TF2 PDB Entries 2bu6 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00734 mg/mL ALOGPS logP 3.17 ALOGPS logP 3.58 Chemaxon logS -4.8 ALOGPS pKa (Strongest Acidic) 9.45 Chemaxon pKa (Strongest Basic) -5.2 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 86.71 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 104.05 m 3 ·mol -1 Chemaxon Polarizability 40.26 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9928 Blood Brain Barrier + 0.6549 Caco-2 permeable - 0.5914 P-glycoprotein substrate Non-substrate 0.6355 P-glycoprotein inhibitor I Non-inhibitor 0.6799 P-glycoprotein inhibitor II Inhibitor 0.6047 Renal organic cation transporter Non-inhibitor 0.9505 CYP450 2C9 substrate Non-substrate 0.5755 CYP450 2D6 substrate Non-substrate 0.8169 CYP450 3A4 substrate Non-substrate 0.5556 CYP450 1A2 substrate Non-inhibitor 0.7909 CYP450 2C9 inhibitor Inhibitor 0.622 CYP450 2D6 inhibitor Non-inhibitor 0.8014 CYP450 2C19 inhibitor Inhibitor 0.6414 CYP450 3A4 inhibitor Inhibitor 0.6999 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.696 Ames test Non AMES toxic 0.689 Carcinogenicity Non-carcinogens 0.5138 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.3824 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9974 hERG inhibition (predictor II) Non-inhibitor 0.7613    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial Kind Protein Organism Humans Pharmacological action Unknown General Function Pyruvate dehydrogenase (acetyl-transferring) kinase activity Specific Function Kinase that plays a key role in the regulation of glucose and fatty acid metabolism and homeostasis via phosphorylation of the pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits pyruvat... Gene Name PDK2 Uniprot ID Q15119 Uniprot Name [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial Molecular Weight 46153.39 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:33 / Updated at June 12, 2020 16:52 